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1 Glossary of Terms: Vision Screening 
Abnormal test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered the 
screening test. 
x Tested and recĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂůƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Attendance rate provides information on the willingness of families 
to participate in screening. 
Compliance with 
referral 
(percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the willingness 
of families to attend the diagnostic assessment after referral from 
screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
ĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to participate, 
missed screening, ability to complete the screen, and ability to 
document the screening results will influence the coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 1%. 
False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
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Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for 
screening 
Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated 
amblyopia 
Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent 
amblyopia 
Amblyopia that is missed by screening, or present after the child 
has received treatment. 
 
 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease or 
condition. Prevalence can either be expressed as a percentage or 
as a number out of 1000 individuals within the same demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be re-
tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors for 
vision defects/ophthalmic pathology according to the screening 
programme. 
 
Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
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Sensitivity The percentage of children with visual defects that are identified 
via the screening program. 
For example, if 100 babies with visual defects are tested, and 98 of 
these babies are referred for diagnostic assessment and 2 pass the 
screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 of 
these babies are referred for diagnostic assessment and90 pass the 
screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy 
babies 
Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
AAO  ? American Academy of Ophthalmology  
GDP  ? Gross Domestic Product 
ICO  ? International Council of Ophthalmology  
NICU  ? Neonatal-intensive care unit 
PPP  ? Purchasing Power Parity 
WHO  ? Word Health Organisation  
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3 Population and Healthcare Overview 
The population of Albania is estimated at 2,800,000 (World Bank, 2018a) and a birth rate 
estimated at 12 births/1,000 population (World Bank, 2018b). The change in population 
and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B respectively.  
Albania had a reported population density of 105 people per square kilometre in 2017 and 
this has risen from 61 people per square kilometre in 1961 (World Bank, 2018c). In terms 
of healthcare facilities, the total density of hospitals in 2013 was 0.72 per 100,000 
population (WHO, 2016a). Infant mortality in 2017 is estimated at 8 deaths/1,000 live 
births (World Bank 2018d). 
The average life expectancy in Albania is estimated at 78 years (World Bank, 2018e), with a 
death rate of 7 deaths/1,000 population in 2016 (World Bank, 2018f). Albania has a gross 
national income per capita (PPP int. $, 2013) of $10,000 (WHO, 2016b). The estimated total 
expenditure on health per capita in 2014 was $615 (Intl $) and the total expenditure on 
health in 2014 as percentage of GDP was 5.9% (WHO, 2016b).  
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Figure 1: Change in the Total Population and Birth Rate in Albania between 1960 and 2017 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
Vision screening in Albania is funded through national health insurance and is not 
embedded into general preventative child healthcare screening. There are no guidelines for 
ophthalmologists to follow however, they are guided by the American Academy of 
Ophthalmology (AAO) and International Council of Ophthalmology (ICO) guidelines. The 
content of the Albanian vision screening programme is decided upon by the Ministry of 
Health and was implemented nationally in 2013, with no changes since its commencement.  
Vision screening is conducted by ophthalmologists, nurses, or paediatricians. No other 
general health care professionals have been identified that do not currently screen, but 
could do so with additional training. There is no specific training provided for vision 
screening; ophthalmologists undertake a 4-year residency where they acquire the skills and 
knowledge to perform such tasks. 
Vision screening is conducted in hospitals or primary service. It is not known how often the 
vision screening programme is reviewed, who decides upon revisions, how revisions are 
funded, or how the revisions take place.  
There are no methods imposed by the government regarding quality monitoring of the 
vision screening programme, but there has been some PhD research concerning the 
programme, the details of this research have not been shared and therefore the content is 
not known. There has been no cost-effectiveness analysis conducted pertaining to the vision 
screening programme, nor studies on the effectiveness of vision screening in Albania.  
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5 Screening programme  
In Albania, retinopathy of prematurity, congenital eye defects and amblyopia are the target 
conditions screened for by vision screening. The health care professionals delivering vision 
screening, venue for screening and tests used vary depending on the age of the child as 
shown in Tables 1, 2 and 3 respectively. Specific details of the screening offered within each 
age group are described more fully in sections 5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies up to the age of 3 months are screened using an eye inspection. This vision 
screening is conducted by an ophthalmologist in either a maternity clinic or an eye clinic.  
5.2 Vision screening - Birth to 3 months 
Well, healthy babies up to the age of 3 months are screened using an eye inspection and red 
reflex examination. These tests are conducted by an ophthalmologist or a nurse in either a 
hospital or primary service. Paediatricians or ophthalmologists perform the fundus red 
reflex examination to diagnose white pupil. The timing and number of eye screenings 
offered during this 3 month period is not clearly defined and it is not known after how many 
abnormal or inconclusive tests a baby is referred for further diagnostic examination.  
5.3 Vision screening - 3 months to 36 months 
Vision screening is conducted on children aged 3 months to 36 months by an 
ophthalmologist at an eye clinic. It is not clear what vision screening tests are performed in 
children aged 3 months to 36 months. It is known that a visual acuity measurement is 
conducted at the age of 2 years, although the method of measurement is not clear and the 
sequence of testing during this period or the referral criteria are not known.  
5.4 Vision screening - 36 months to 7 years 
Children aged 36 months to 7 years are screened by either an ophthalmologist or a 
paediatrician ŝŶĂƉƌŝŵĂƌǇĐĂƌĞĐůŝŶŝĐ ?ƵƐŝŶŐĂŶĞǇĞŝŶƐƉĞĐƚŝŽŶĂŶĚĂŶƵŶƐƉĞĐŝĨŝĞĚ ?ŽƚŚĞƌ ?ƚĞƐƚ ?
The timing and frequency of vision screening at any other age between 36 months and 7 
years is not known and it is not known after how many abnormal or inconclusive tests a 
child is referred for further diagnostic examination. Visual acuity is measured at age 3 to 4 
years by an ophthalmologist, using Lea Symbols, HOTV, Keeler, Snellen, Allen Cards or 
Numbers. Visual acuity is repeated at ages 6 to 7 years. It is not known how many abnormal 
or inconclusive tests necessitate a child to be referred for further diagnostic examination. 
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1  Paediatrician Ophthalmologist Nurse 
Preterm babies  
× 
 
 
9 
 
 
× 
 
 
0 to 3 months  
9 
 
 
9 
 
 
9 
 
 
3 to 36 months  
× 
 
 
9 
 
 
× 
 
 
3 to 7 years  
9 
 
 
9 
 
 
× 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2  Eye inspection Red Reflex 
Visual Acuity 
Measurement 
Other 
Preterm babies  
9 
 
 
× 
 
 
× 
 
 
× 
 
 
0 to 3 months  
9 
 
 
9 
 
 
× 
 
 
× 
 
 
3 to 36 months  
× 
 
 
× 
 
 
9 
 
 
× 
 
 
3 to 7 years  
× 
 
 
× 
 
 
9 
 
 
9 
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Table 3: Location of vision screening for each age group  
 Table 3 Maternity Eye Clinic Hospital Primary Care Clinic 
Preterm babies  
9 
 
 
9 
 
 
× 
 
 
× 
 
 
0 to 3 months  
× 
 
 
× 
 
 
9 
 
 
9 
 
 
3 to 36 months  
× 
 
 
9 
 
 
× 
 
 
× 
 
 
3 to 7 years  
× 
 
 
× 
 
 
× 
 
 
9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results 
and is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss.  
Automated vision screening is used in Albania, but only in the private sector (therefore not 
every child who attends vision screening has automated vision screening). The content of 
this private sector vision screening is not clear. These devices cost approximately 5,000 
Euros, however, the maintenance costs and the number of years before a device is 
scheduled to be replaced are not known. 
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7 Provision for Visually Impaired  
In Albania, there is one school for blind children, it is located in Tirana and accommodates 
around 60 pupils. There are specific lessons concerning Braille writing and this school is 
supported by the Albanian government. The costs per child for these schools and whether 
or not there is any special support for visually impaired children who attend regular primary 
school is not known.  
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8 Knowledge of existing screening programme 
8.1 Prevalence/Diagnosis  
There is no information provided pertaining to the prevalence and diagnosis of vision 
disorders in children aged up to 7 years.  
8.2 Coverage 
All children commencing school at the age of 6 years are invited and must attend vision 
screening. There is no information provided relating to the coverage and treatment success 
of vision disorders in children aged up to 7 years. The coverage and subsequent attendance 
rates of vision screening are not known.  
8.3 Screening Evaluation  
There is no information provided pertaining to the screening outcomes of vision disorders in 
children aged up to 7 years.  
8.3 Treatment success 
Ophthalmologists prescribe glasses to children under the age of 7 years; other treatments 
include patching and cataract surgery. All eligible children are offered treatment. There is no 
information provided pertaining to treatment outcomes.  
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9 Costs of vision screening in children 
In Albania, vision screening is free of charge for parents and there is no financial reward for 
attending and no penalty for not attending a vision screening appointment. 
9.1 Cost of vision screening 
There is no information provided relating to the costs of performing vision screening in 
children aged up to 7 years.  
9.2 Cost of treatment for amblyopia 
There is not information provided relating to the costs of treatment for amblyopia in 
children aged up to 7 years.  
9.3 Cost of Treatment for strabismus  
There is not information provided relating to the costs of treatment for strabismus in 
children aged up to 7 years.  
9.4 Cost of treatment for cataract 
There is not information provided relating to the costs of treatment for cataract in children 
aged up to 7 years.  
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